Dr. Vito Imbasciani was sworn in as the new Chair of the Board of the California Institute for Regenerative Medicine (CIRM) at its March meeting. Imbasciani (pictured above at left) was elected to the six-year term at CIRM’s January Board meeting. He will replace outgoing chair Jonathan Thomas, who has served in the position since 2011. “My experience … Continue reading CIRM welcomes new Chair, bids farewell to Art Torres and Jonathan Thomas
Board Meeting
CIRM Board Appoints Dr. Maria Millan as President and CEO
Yesterday was a big day for CIRM. Our governing Board convened for its September ICOC meeting and appointed Dr. Maria Millan as our new President and CEO. Dr. Millan has been serving as the Interim President/CEO since July, replacing former President Dr. Randal Mills. Dr. Millan has been at CIRM since 2012 and was instrumental … Continue reading CIRM Board Appoints Dr. Maria Millan as President and CEO
Partnering with the best to help find cures for rare diseases
As a state agency we focus most of our efforts and nearly all our money on California. That’s what we were set up to do. But that doesn’t mean we don’t also look outside the borders of California to try and find the best research, and the most promising therapies, to help people in need. … Continue reading Partnering with the best to help find cures for rare diseases
With an eye toward 2020, CIRM looks at clinical milestones achieved in 2016
One year ago, CIRM announced its strategic plan for the next five years. It’s a bold vision to maximize our impact in stem cell research by accelerating stem cell treatments to patients with unmet medical needs. Our strategic plan, which can be found on our website, details how CIRM will invest in five main program … Continue reading With an eye toward 2020, CIRM looks at clinical milestones achieved in 2016
One man’s story points to hope against a deadly skin cancer
One of the great privileges and pleasures of working at the stem cell agency is the chance to meet and work with some remarkable people, such as my colleagues here at CIRM and the researchers we support. But for me the most humbling, and by far the most rewarding experience, is having a chance to … Continue reading One man’s story points to hope against a deadly skin cancer
Faster, better, more efficient. Challenging? That too. An update on CIRM 2.0.
Changing direction is never easy. The greater the change the greater the likelihood you’ll have to make adjustments and do some fine-tuning along the way to make sure you get it right. On January 1st of this year we made a big change, launching CIRM 2.0. Our President and CEO Dr. C. Randal Mills called … Continue reading Faster, better, more efficient. Challenging? That too. An update on CIRM 2.0.
Getting the right tools for the right job
Imagine a device that sits outside the body and works like a form of dialysis for a damaged liver, filtering out the toxins and giving the liver a chance to regenerate, and the patient a chance to avoid the need for a transplant. Or imagine a method of enhancing the number of stem cells we … Continue reading Getting the right tools for the right job
Spiderman Sets the Tone for Stem Cell Agency Board Meeting
I don’t often think about Spiderman at meetings of our governing Board – no, really I don’t - but yesterday was an exception. Not that I was daydreaming, rather I was listening to our new President & CEO C. Randal Mills, Ph.D., talk about his determination to set a very specific tone in leading the … Continue reading Spiderman Sets the Tone for Stem Cell Agency Board Meeting
A Second Chance for a Spinal Cord Injury Trial, and a Powerful Reminder from Patient Advocates
Yesterday’s meeting of our governing Board was important for a number of reasons. First, the Board voted to invest some $32 million to try and get two promising projects into clinical trials – more on that in a minute – and also to try and attract some world-class researchers to California through our Research Leadership … Continue reading A Second Chance for a Spinal Cord Injury Trial, and a Powerful Reminder from Patient Advocates
The Stem Cellar 